Загрузка...
An antigen-encapsulating nanoparticle platform for T(H)1/17 immune tolerance therapy
Tolerogenic nanoparticles (NPs) are rapidly being developed as specific immunotherapies to treat autoimmune disease. However, many NP-based therapies conjugate antigen (Ag) directly to the NP posing safety concerns due to antibody binding or require the co-delivery of immunosuppressants to induce to...
Сохранить в:
| Опубликовано в: : | Nanomedicine |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5237397/ https://ncbi.nlm.nih.gov/pubmed/27720992 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nano.2016.09.007 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|